Description
8,00,000 equity shares of Vanta Bioscience Limited issued on preferential basis to promoters listed and permitted to trade from October 17, 2025.
Summary
BSE has announced the listing of 8,00,000 new equity shares of Vanta Bioscience Limited (Scrip Code: 540729) issued to promoters on a preferential basis. The shares will be listed and permitted to trade from Friday, October 17, 2025. The shares were allotted at Rs. 50/- (Rs. 10/- face value plus Rs. 40/- premium) and are subject to a lock-in period until April 29, 2027.
Key Points
- 8,00,000 equity shares of Rs. 10/- each issued at a premium of Rs. 40/-
- Issue price: Rs. 50/- per share
- Issued to promoters on preferential basis
- Date of allotment: May 6, 2025
- Trading commencement: October 17, 2025
- Shares ranking pari-passu with existing equity shares
- Distinctive numbers: 6312001 to 7112000
- ISIN: INE695X01011
Regulatory Changes
No regulatory changes. This is a standard listing notification for preferential allotment.
Compliance Requirements
Trading members are informed of the new securities listing. All 8,00,000 shares are subject to mandatory lock-in restrictions and cannot be traded until the lock-in period expires.
Important Dates
- Date of Allotment: May 6, 2025
- Trading Commencement: October 17, 2025
- Lock-in Period Ends: April 29, 2027
- Notice Date: October 16, 2025
Impact Assessment
Minimal market impact expected. This is a routine preferential allotment to promoters representing capital raising activity. The shares are subject to a two-year lock-in period, preventing immediate trading by promoters. The issue size is relatively small and will not significantly affect the company’s existing shareholding pattern or market liquidity in the near term.
Impact Justification
Routine preferential allotment to promoters with standard lock-in period. Limited market impact due to small issue size and promoter-only participation.